Back
 OJGen  Vol.9 No.2 , June 2019
HLA-G 3’UTR 14 bp Insertion Is Associated with a Decreased Risk of Developing Human African Trypanosomiasis in the Côte d’Ivoire Population
Abstract: Human African trypanosomiasis (HAT), or sleeping sickness, caused by Trypanosoma brucei gambiense, is associated with diverse clinical outcomes. Host’s genetic factors involved in immunity are potential factors that can regulate infection. Genetic polymorphisms within HLA-G could influence the level of HLA-G expression and therefore play a critical role in infection outcomes. The goal of our study was to investigate the association of 14 bp Indel HLA-G polymorphism with the susceptibility/resistance to HAT. DNA samples were collected from 119 cases, 221 controls and 43 seropositive individuals living in Ivorian HAT foci. The 14 bp Indel polymorphism was determined by PCR. Homozygous individuals for 14 bp insertion had a lower risk of progressing to active HAT (p = 0.012, OR = 0.27, 95% CI: 0.09 - 0.8). Moreover, the frequency of 14 bp insertion homozygous genotype was higher in the seropositive group (11%) than in the HAT cases group (3%) (p = 0.043, OR = 0.27, 95% CI: 0.07 - 0.99), which suggested a protective effect of 14 bp insertion homozygous genotype. Genetic polymorphisms in HLA-G may be associated with a variable risk to develop HAT. The 14 bp insertion appears to favour the occurrence of long-lasting T. b. gambiense latent infections.
Cite this paper: Ahouty, B. , Koffi, M. , Courtin, D. , Hamidou, I. , Sokouri, D. , Abé, I. , Gineau, L. , Konan, T. , Kouakou, L. , Sanogo, T. , Matovu, E. , Bucheton, B. , Jamonneau, V. and N’Guetta, S. (2019) HLA-G 3’UTR 14 bp Insertion Is Associated with a Decreased Risk of Developing Human African Trypanosomiasis in the Côte d’Ivoire Population. Open Journal of Genetics, 9, 31-41. doi: 10.4236/ojgen.2019.92003.
References

[1]   Jamonneau, V., Ilboudo, H., Kaboré, J., Kaba, D., Koffi, M., Solano, P., Garcia, A., Courtin, D., Laveissière, C., Lingue, K., Büscher, P. and Bucheton, B. (2012) Untreated Human Infections by Trypanosoma brucei gambiense Are Not 100% Fatal. PLoS Neglected Tropical Diseases, 6, e1691.
https://doi.org/10.1371/journal.pntd.0001691

[2]   Bucheton, B., MacLeod, A. and Jamonneau, V. (2011) Human Host Determinants Influencing the Outcome of Trypanosoma brucei gambiense Infections. Parasite Immunology, 33, 438-447.
https://doi.org/10.1111/j.1365-3024.2011.01287.x

[3]   Checchi, F., Filipe, J.A.N., Barrett, M.P. and Chandramohan, D. (2008) The Natural Progression of Gambiense Sleeping Sickness: What Is the Evidence? PLoS Neglected Tropical Diseases, 2, e303.
https://doi.org/10.1371/journal.pntd.0000303

[4]   Iraqi, F., Clapcott, S.J., Kumari, P., Haley, C.S., Kemp, S.J. and Teale, A.J. (2000) Fine Mapping of Trypanosomiasis Resistance Loci in Murine Advanced Intercross Lines. Mammalian Genome, 11, 645-648.
https://doi.org/10.1007/s003350010133

[5]   Kemp, S.J., Iraqi, F., Darvasi, A., Soller, M. and Teale, A.J. (1997) Localization of Genes Controlling Resistance to Trypanosomiasis in Mice. Nature Genetics, 16, 194-196.
https://doi.org/10.1038/ng0697-194

[6]   Courtin, D., Argiro, L., Jamonneau, V., N'dri, L., N’guessan, P., Abel, L., Dessein, A., Cot, M., Laveissiere, C. and Garcia, A. (2006) Interest of Tumor Necrosis Factor-Alpha −308 G/A and Interleukin-10 −592 C/A Polymorphisms in Human African Trypanosomiasis. Infection, Genetics and Evolution, 6, 123-129.
https://doi.org/10.1016/j.meegid.2005.03.002

[7]   Courtin, D., Jamonneau, V., Mathieu, J.-F., Koffi, M., Milet, J., Yeminanga, C.S., Kumeso, V.K., Cuny, G., Bilengue, C.M. and Garcia, A. (2006) Comparison of Cytokine Plasma Levels in Human African Trypanosomiasis. Tropical Medicine & International Health, 11, 647-653.
https://doi.org/10.1111/j.1365-3156.2006.01612.x

[8]   Courtin, D., Milet, J., Jamonneau, V., Yeminanga, C.S., Kumeso, V.K., Bilengue, C.M., Betard, C. and Garcia, A. (2007) Association between Human African Trypanosomiasis and the IL6 Gene in a Congolese Population. Infection, Genetics and Evolution, 7, 60-68.
https://doi.org/10.1016/j.meegid.2006.04.001

[9]   Cuypers, B., Lecordier, L., Meehan, C.J., Van den Broeck, F., Imamura, H., Buscher, P., Dujardin, J.-C., Laukens, K., Schnaufer, A., Dewar, C., Lewis, M., Balmer, O., Azurago, T., Kyei-Faried, S., Ohene, S.-A., Duah, B., Homiah, P., Mensah, E.K., Anleah, F., Franco, J.R., Pays, E. and Deborggraeve, S. (2016) Apolipoprotein L1 Variant Associated with Increased Susceptibility to Trypanosome Infection. American Society for Microbiology, 7, e02198-02115.
https://doi.org/10.1128/mBio.02198-15

[10]   Hardwick, R.J., Menard, A., Sironi, M., Milet, J., Garcia, A., Sese, C., Yang, F,-T., Fu, B.-Y., Courtin, D. and Hollox, E.J. (2014) Haptoglobin (HP) and Haptoglobin-Related Protein (HPR) Copy Number Variation, Natural Selection, and Trypanosomiasis. Human Genetics, 133, 69-83.
https://doi.org/10.1007/s00439-013-1352-x

[11]   Kaboré, J.W., Ilboudo, H., Noyes, H., Camara, O., Kaboré, J., Camara, M., Koffi, M., Lejon, V., Jamonneau, V., MacLeod, A., Hertz-Fowler, C., Belem, A.M.G., Matovu, E., Bucheton, B. and Sidibe, I. (2017) Candidate Gene Polymorphisms Study between Human African Trypanosomiasis Clinical Phenotypes in Guinea. PLoS Neglected Tropical Diseases, 11, e0005833.
https://doi.org/10.1371/journal.pntd.0005833

[12]   Moon, A., Kim, S.K., Chung, J.H., Na, K.Y., Olvi, L.G., Santini-Araujo, E., Kim, Y.W. and Park, Y.K. (2011) 14-bp Insertion/Deletion Polymorphism of the HLA-G Gene in Osteosarcoma Patients. The Korean Journal of Pathology, 45, 485-490.
https://doi.org/10.4132/KoreanJPathol.2011.45.5.485

[13]   Carosella, E.D. (2011) The Tolerogenic Molecule HLA-G. Immunology Letters, 138, 22-24.
https://doi.org/10.1016/j.imlet.2011.02.011

[14]   Carosella, E.D., Rouas-Freiss, N., Tronik-Le Roux, D., Moreau, P. and LeMaoult, J. (2015) HLA-G: An Immune Checkpoint Molecule. Advances in Immunology, 127, 33-144.
https://doi.org/10.1016/bs.ai.2015.04.001

[15]   Le Bouteiller, P. and Lenfant, F. (1997) Gène HLA-G: Le plus classique des non classiques. Médecine/Sciences, 13, 1436-1444.
https://doi.org/10.4267/10608/575

[16]   Donadi, E.A., Castelli, E.C., Arnaiz-Villena, A., Roger, M., Rey, D. and Moreau, P. (2011) Implications of the Polymorphism of HLA-G on Its Function, Regulation, Evolution and Disease Association. Cellular and Molecular Life Sciences, 68, 369-395.
https://doi.org/10.1007/s00018-010-0580-7

[17]   Hviid, T.V., Hylenius, S., Rorbye, C. and Nielsen, L.G. (2003) HLA-G Allelic Variants Are Associated with Differences in the HLA-G mRNA Isoform Profile and HLA-G mRNA Levels. Immunogenetics, 55, 63-79.

[18]   Rousseau, P., Le Discorde, M., Mouillot, G., Marcou, C., Carosella, E.D. and Moreau, P. (2003) The 14 bp Deletion-Insertion Polymorphism in the 3' UT Region of the HLA-G Gene Influences HLA-G mRNA Stability. Human Immunology, 64, 1005-1010.
https://doi.org/10.1016/j.humimm.2003.08.347

[19]   Amiot, L., Vu, N. and Samson, M. (2014) Immunomodulatory Properties of HLA-G in Infectious Diseases. Journal of Immunology Research, 2014, Article ID: 298569.
https://doi.org/10.1155/2014/298569

[20]   Courtin, D., Milet, J., Sabbagh, A., Massaro, J.D., Castelli, E.C., Jamonneau, V., Bucheton, B., Sese, C., Favier, B., Rouas-Freiss, N., Moreau, P., Donadi, E.A. and Garcia, A. (2013) HLA-G 3’ UTR-2 Haplotype is Associated with Human African Trypanosomiasis Susceptibility. Infection, Genetics and Evolution, 17, 1-7.
https://doi.org/10.1016/j.meegid.2013.03.004

[21]   Ahouty, B., Koffi, M., Ilboudo, H., Simo, G., Matovu, E., Mulindwa, J., Hertz-Fowler, C., Bucheton, B., Sidibé, I., Jamonneau, V., MacLeod, A., Noyes, H. and N’Guetta, S.P. (2017) Candidate Genes-Based Investigation of Susceptibility to Human African Trypanosomiasis in Côte d’Ivoire. PLoS Neglected Tropical Diseases, 11, e0005992.
https://doi.org/10.1371/journal.pntd.0005992

[22]   Jamonneau, V., Bucheton, B., Kabore, J., Ilboudo, H., Camara, O., Courtin, F., Solano, P., Kaba, D., Kambire, R., Lingue, K., Camara, M., Baelmans, R., Lejon, V. and Buscher, P. (2010) Revisiting the Immune Trypanolysis Test to Optimise Epidemiological Surveillance and Control of Sleeping Sickness in West Africa. PLoS Neglected Tropical Diseases, 4, e917.
https://doi.org/10.1371/journal.pntd.0000917

[23]   Lumsden, W.H.R., Kimber, C.D., Evans, D.A. and Doig, S.J. (1979) Trypanosoma brucei: Miniature Anion-Exchange Centrifugation Technique for Detection of Low Parasitaemias: Adaptation for Field Use. Transactions of the Royal Society of Tropical Medicine and Hygiene, 73, 312-317.
https://doi.org/10.1016/0035-9203(79)90092-0

[24]   Magnus, E., Vervoort, T. and Van Meirvenne, N. (1978) A Card-Agglutination Test with Stained Trypanosomes (C.A.T.T.) for the Serological Diagnosis of T. B. Gambiense trypanosomiasis. Annales de la Société Belge de Médecine Tropicale, 58, 169-176.

[25]   Silva, H.P., Ururahy, M., Souza, K.S., Loureiro, M.B., Oliveira, Y.M., Oliveira, G.H., Luchessi, A.D., Carvalho, K.T., Freitas, J.C., Donadi, E.A., Hirata, R.D., Almeida, M.G., Arrais, R.F., Hirata, M.H. and Rezende, A.A. (2016) The Association between the HLA-G 14-bp Insertion/Deletion Polymorphism and Type 1 Diabetes. Genes Immunity, 17, 13-18.
https://doi.org/10.1038/gene.2015.45

[26]   Berger, D.S., Hogge, W.A., Barmada, M.M. and Ferrell, R.E. (2010) Comprehensive Analysis of HLA-G: Implications for Recurrent Spontaneous Abortion. Reproductive Sciences, 17, 331-338.
https://doi.org/10.1177/1933719109356802

[27]   Dias, F.C., Castelli, E.C., Collares, C.V., Moreau, P. and Donadi, E.A. (2015) The Role of HLA-G Molecule and HLA-G Gene Polymorphisms in Tumors, Viral Hepatitis, and Parasitic Diseases. Frontiers in Immunology, 6, Article 9.
https://doi.org/10.3389/fimmu.2015.00009

[28]   Garcia, A., Milet, J., Courtin, D., Sabbagh, A., Massaro, J.D., Castelli, E.C., Migot-Nabias, F., Favier, B., Rouas-Freiss, N., Donadi, E.A. and Moreau, P. (2013) Association of HLA-G 3’UTR Polymorphisms with Response to Malaria Infection: A First Insight. Infection, Genetics and Evolution, 16, 263-269.
https://doi.org/10.1016/j.meegid.2013.02.021

[29]   Sabbagh, A., Courtin, D., Milet, J., Massaro, J.D., Castelli, E.C., Migot-Nabias, F., Favier, B., Rouas-Freiss, N., Moreau, P., Garcia, A. and Donadi, E.A. (2013) Association of HLA-G 3’ Untranslated Region Polymorphisms with Antibody Response Against Plasmodium Falciparum Antigens: Preliminary Results. Tissue Antigens, 82, 53-58.
https://doi.org/10.1111/tan.12140

[30]   Sadissou, I., d'Almeida, T., Cottrell, G., Luty, A., Krawice-Radanne, I., Massougbodji, A., Moreau, P., Moutairou, K., Garcia, A., Favier, B., Rouas-Freiss, N. and Courtin, D. (2014) High Plasma Levels of HLA-G Are Associated with Low Birth Weight and with an Increased Risk of Malaria in Infancy. Malaria Journal, 13, Article ID: 312.
https://doi.org/10.1186/1475-2875-13-312

[31]   Celsi, F., Catamo, F., Kleiner, G., Tricarico, P.M., Vuch, J. and Crovella, S. (2013) HLA-G/C, miRNAs, and Their Role in HIV Infection and Replication. BioMed Research International, 2013, Article ID: 693643.
https://doi.org/10.1155/2013/693643

[32]   Berthier, D., Peylhard, M., Dayo, G.K., Flori, L., Sylla, S., Bolly, S., Sakande, H., Chantal, I. and Thevenon, S. (2015) A comparison of Phenotypic Traits Related to Trypanotolerance in Five West African Cattle Breeds Highlights the Value of Shorthorn Taurine Breeds. PLoS ONE, 10, e0126498.
https://doi.org/10.1371/journal.pone.0126498

[33]   Gineau, L., Courtin, D., Camara, M., Ilboudo, H., Jamonneau, V., Dias, F.C., Tokplonou, L., Milet, J., Mendonca, P.B., Castelli, E.C., Camara, O., Camara, M., Favier, B., Rouas-Freiss, N., Moreau, P., Donadi, E.A., Bucheton, B., Sabbagh, A. and Garcia, A. (2016) Human Leukocyte Antigen-G: A Promising Prognostic Marker of Disease Progression to Improve the Control of Human African Trypanosomiasis. Clinical Infectious Diseases, 63, 1189-1197.
https://doi.org/10.1093/cid/ciw505

 
 
Top